Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology
Year: 2014
Type: article
Study design: Clinical Trial
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Dermatology Foundation, Amgen, Eli Lilly and Company, Pfizer, GlaxoSmithKline, Celgene, Rockefeller University, Dermira, Strong, Georgia Clinical and Translational Science Alliance, National Institutes of Health, Genentech, National Center for Research Resources, National Center for Advancing Translational Sciences
OpenAlex ID: W2062276423
